Dr. Lal PathLabs Limited (BOM:539524)
1,439.80
+22.45 (1.58%)
At close: Apr 21, 2026
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 240.13 billion as of April 21, 2026. Its market cap has increased by 15.83% in one year.
Market Cap
240.13B
Enterprise Value
229.02B
Revenue
26.63B
Ranking
n/a
PE Ratio
45.45
Stock Price
1,439.80
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 240.13B, an increase of 252.19%. That is a compound annual growth rate of 12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 240.13B | -3.07% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thyrocare Technologies | 61.73B |
| One Global Service Provider | 10.86B |
| Chandan Healthcare | 6.45B |
| Star Imaging and Path Lab | 1.32B |
| Modern Diagnostic & Research Centre | 1.17B |
| Invicta Diagnostic | 980.61M |
| Aspira Pathlab & Diagnostics | 576.51M |
| Family Care Hospitals | 172.85M |